Finance

Lists
Why is TDOC down 3,17%?
Dive Deeper
TDOC:NYSE
Teladoc Health Inc
5,81 USD
-3,17%
(-0,19) 1D
5,75 USD
-1,03% (-0,060)
After hours
Closed: 14-окт., 16:00:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TDOC...
Open
5,81 USD
High
5,96 USD
Low
5,71 USD
Mkt. cap
1,06 млд
Avg. vol.
3,54 млн
Volume
0,00
52-wk high
9,89 USD
52-wk low
4,40 USD
EPS
-0,99 USD
Beta
2,14
Shares outstanding
181,68 млн
No. of employees
5 миң
Open
5,81 USD
High
5,96 USD
Low
5,71 USD
Mkt. cap
1,06 млд
Avg. vol.
3,54 млн
Volume
0,00
52-wk high
9,89 USD
52-wk low
4,40 USD
EPS
-0,99 USD
Beta
2,14
Shares outstanding
181,68 млн
No. of employees
5 миң
News stories
From web sources and news partners
Profile
Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services. The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025. Wikipedia
About Teladoc Health Inc
CEO-
Employees5,12 миң
Founded2002
Headquarters-
SectorHealth care
Analyst ratings
Based on 16 analysts giving stock ratings to TDOC in the past 3 months
Hold
Buy
4
Hold
12
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for TDOC in the last 3 months.
Highest
Current 5,81 USD
10,50 USD (+80,72%)
Average
7,67 USD (+32,01%)
Lowest
5,50 USD (-5,34%)
Analyst
Recommendation
Action
Price target
Projected
Date
Allen Lutz
Bank of America Securities
Buy
Maintained
10,50 USD
+80,7%
09/24/2026
Richard Close
Canaccord Genuity
Buy
Maintained
10,00 USD
+72,1%
08/31/2026
Jailendra Singh
Truist Financial
Hold
Maintained
-
-
09/01/2026
Michael Wiederhorn
Oppenheimer
Buy
Reiterated
7,00 USD
+20,5%
08/04/2026
Charles Rhyee
TD Cowen
Hold
Maintained
6,00 USD
+3,3%
08/03/2026
Daniel Grosslight
Citi
Hold
Maintained
7,50 USD
+29,1%
08/03/2026
Peter Warendorf
Barclays
Hold
Maintained
7,00 USD
+20,5%
08/03/2026
Stan Berenshteyn
Wells Fargo
Hold
Maintained
6,00 USD
+3,3%
07/30/2026
Brian Tanquilut
Jefferies
Hold
Maintained
8,00 USD
+37,7%
07/30/2026
David Grossman
Stifel Nicolaus
Hold
Maintained
5,50 USD
-5,3%
07/30/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
7,50 USD
+29,1%
07/30/2026
Sean Dodge
BMO Capital
Hold
Reiterated
7,00 USD
+20,5%
07/29/2026
Sarah James
Cantor Fitzgerald
Buy
Maintained
10,00 USD
+72,1%
07/29/2026
Ryan MacDonald
Needham
Hold
Reiterated
-
-
07/30/2026
David Larsen
BTIG
Hold
Reiterated
-
-
07/29/2026
Ryan Daniels
William Blair
Hold
Reiterated
-
-
07/29/2026
David Roman
Goldman Sachs
Buy
Maintained
8,00 USD
+37,7%
05/27/2026
Kevin Caliendo
UBS
Hold
Maintained
6,00 USD
+3,3%
05/15/2026
Lisa Gill
J.P. Morgan
Hold
Reiterated
7,00 USD
+20,5%
03/13/2026
George Hill
Deutsche Bank
Buy
Upgraded
11,00 USD
+89,3%
03/10/2026
Scott Schoenhaus
KeyBanc
Hold
Maintained
-
-
02/27/2026
Steven Valiquette
Mizuho Securities
Hold
Maintained
6,00 USD
+3,3%
02/26/2026
Jessica Tassan
Piper Sandler
Buy
Reiterated
9,00 USD
+54,9%
02/26/2026
Next call 14 күндөн кийин
28-окт., шарш., 23:00
Fiscal period
Q3 2026
- / -0,19 USD
Revenue / Est. (USD)
- / 592,31 млн
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
626,44 млн
642,27 млн
613,84 млн
606,93 млн
Cost of goods sold
187,18 млн
197,05 млн
197,53 млн
190,84 млн
Cost of revenue
187,18 млн
197,05 млн
197,53 млн
190,84 млн
Research and development expenses
67,57 млн
71,61 млн
67,86 млн
62,86 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
318,78 млн
305,74 млн
304,90 млн
296,82 млн
Operating expense
474,72 млн
472,19 млн
465,05 млн
450,59 млн
Total operating expenses
661,90 млн
669,24 млн
662,57 млн
641,42 млн
Operating income
-35,46 млн
-26,97 млн
-48,73 млн
-34,50 млн
Other non operating income
-815,00 миң
378,00 миң
-196,00 миң
-2,19 млн
EBT including unusual items
-50,22 млн
-33,62 млн
-60,84 млн
-37,91 млн
EBT excluding unusual items
-33,72 млн
-24,59 млн
-47,80 млн
-35,32 млн
Income tax expense
-715,00 миң
-8,48 млн
3,00 млн
997,00 миң
Effective tax rate
1,42%
25,21%
-4,92%
-2,63%
Other operating expenses
-
-
-
-
Net income
-49,51 млн
-25,14 млн
-63,84 млн
-38,91 млн
Net profit margin
-7,90%
-3,91%
-10,40%
-6,41%
Earnings per share
-0,19
-0,10
-0,28
-0,20
Interest and investment income
7,08 млн
6,95 млн
6,49 млн
6,48 млн
Interest expense
-4,53 млн
-4,95 млн
-5,37 млн
-5,11 млн
Net interest expenses
2,56 млн
2,00 млн
1,12 млн
1,37 млн
Depreciation and amortization charges
2,61 млн
2,80 млн
2,46 млн
2,47 млн
EBITDA
10,68 млн
28,67 млн
5,48 млн
19,73 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google колдонмолору